Advisor(s)
Abstract(s)
Context:Immunosuppressive agentes are associated with profound metabolic side effects including
new-onset diabetes and dyslipidemia after organ transplantation.
Objective: Toi nvestigated the effects of the cyclosporine A(CsA)or tacrolimus ong lucose uptake
and insulin signalling in human adipocytes and their impact on the regulation of celular trafficking
of the glucose transporter 4 (GLUT4).
Design:Human isolated adipocytes were incubated with therapeutic concentrations of either CsA
or tacrolimus, and glucose uptake and expression of insulin signaling proteins were assessed.
Furthermore,we studied effects of CsA and tacrolimus on the regulation of celular trafficking of
the GLUT4 in differentiated human pre-adipocytes and L6 cells.
Results:CsA and tacrolimus had a concentration-dependent inhibitory effect on basal and insulin stimulated
14C-glucose uptake in adipocytes. Although phosphorylation at Tyr1146 of insulin receptor
(IR) was inhibited by tacrolimus, the phosphorylation and/or protein levels of the insulin signalling proteinsIRS1/2,p85-PI3K,PKB,AS160 and mTORC1,as well as GLUT4 and GLUT1,were
unchanged by CsA or tacrolimus. Furthermore, CsA and tacrolimus reduced the GLUT4 amount
localized at the cell surfasse of differentiated human pre-adipocytes and L6 cells in the presence of
insulin.This occurred by na increased rate of GLUT4 endocytosis,with no change in the exocytosis
rate.
Conclusions: These results suggest that therapeutic concentrations of CsA and tacrolimus can
inhibit glucose uptake independente of insulin signalling by removing GLUT4 from the cell surface
via na increased rate of endocytosis.Such mechanisms can contribute to the development of insulin
resistance and diabetes associated with immunosuppressive therapy.In addition,they may provide
novel pharmacological approaches for treatment of diabetes.
Description
Keywords
Cyclosporine A Tacrolimus GLUT4